Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies

Personalized Medicine

Volumn 10, Issue 1, 2013, Pages 81-87

  Tarini, Beth A ^a   Lantos, John D ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

biobanking; genetics; newborn screening; screening

Indexed keywords

DNA;

CONGENITAL HEART DISEASE; DEATH; DECISION MAKING; DISABILITY; GENETIC ANALYSIS; GOVERNMENT; HEALTH PROGRAM; HUMAN; NEWBORN SCREENING; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 84871419842     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.12.115     Document Type: Review

References (49)

1. Newborn screening: Toward a uniform screening panel and system. Genet Med. 8(SUPPL1), 1S -252S (2006
2. Hiller EH, Landenburger G, Natowic MR. Public participation in medical policy-making and the status of consumer autonomy: The example of newborn-screening programs in the United States. Am. J. Public Health 87, 1280-1288 (1997
3. Therrell BL, Johnson A, Williams D. Status of newborn screening programs in the United States. Pediatrics 117(5 PT2), S212-S252 (2006
4. Wilson JM, Junger YG. Principles and practice of screening for disease. Bol. Oficina Sanit. Panam. 65(4), 281-393 (1968
5. Clinical and Laboratory Standards Institute. Blood collection on filter paper for newborn screening programs; approved standard. Fifth edition. CLSI document LA4-A5 (2007
6. Gostin L. Public Health Law: Power, Duty, Restraint. University of California Press, Berkeley, CA, USA (2000
7. Mandl KD, Feit S, Larson C, Kohane IS. Newborn screening program practices in the United States: Notification, research, and consent. Pediatrics 109(2), 269-273 (2002
8. Davis TC, Humiston SG, Arnold CL et al. Recommendations for effective newborn screening communication: Results of focus groups with parents, providers, and experts. Pediatrics 117(5 PT2), S326-S340 (2006
9. Deluca JM, Kearney MH, Norton SA, Arnold GL. Parents' experiences of expanded newborn screening evaluations. Pediatrics 128(1), 53-61 (2011
10. Lewis MH, Goldenberg A, Anderson R, Rothwell E, Botkin J. State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 127(4), 703-712 (2011
11. Therrell BL, Hannon WH. Newborn dried blood spot screening: Residual specimen storage issues. Pediatrics 129, 365-366 (2012
12. Benkendorf J, Goodspeed T, Watson MS. Newborn screening residual dried blood spot use for newborn screening quality improvement. Genet Med 12(SUPPL12), S269-S272 (2010
13. Therrell BL, Hannon WH, Pass KA et al. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional Networks for Genetic Services. Biochem. Mol. Med. 57(2), 116-124 (1996
14. Schimmenti LA, Warman B, Schleiss MR et al. Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening. Genet. Med. 13, 1006-1010 (2011
15. Hardin J, Finnell RH, Wong D et al. Whole genome microarray analysis, from neonatal blood cards. BMC Genet. 10, 38 (2009
16. Winkel BG, Hollegaard MV, Olesen MS et al. Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis. BMC Med. Genet. 12, 22 (2011
17. Hakimian R, Korn D. Ownership and use of tissue specimens for research. JAMA 292(20), 2500-2505 (2004
18. Meslin EM, Quaid KA. Ethical issues in the collection, storage, and research use of human biological materials. J. Lab. Clin. Med. 144(5), 229-234 (2004
19. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. Int. J. Law Psychiatry 5(3-4), 319-329 (1982
20. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent. Rep. 17(2), 20-24 (1987
21. Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Washington DC, May 10-11, 1999. Pediatrics 106(2 PT2), 383-427 (2000
22. Tarini BA, Burke W, Scott CR, Wilfond BS. Waiving informed consent in newborn screening research: Balancing social value and respect. Am. J. Med. Genet. C Semin. Med. Genet. 148(1), 23-30 (2008
23. Perrin JM, Knapp AA, Browning MF et al. An evidence development process for newborn screening. Genet. Med. 12(3), 131-134 (2010
24. Botkin JR, Clayton EW, Fost NC et al. Newborn screening technology: Proceed with caution. Pediatrics 117(5), 1793-1799 (2006
25. Botkin Jr. Research for newborn screening: Developing a national framework. Pediatrics 116(4), 862-871 (2005
26. Pass K, Green NS, Lorey F, Sherwin J, Comeau AM. Pilot programs in newborn screening. Ment. Retard. Dev. Disabil. Res. Rev. 12(4), 293-300 (2006
27. Ross LF. Screening for conditions that do not meet the wilson and jungner criteria: The case of duchenne muscular dystrophy. Am. J. Med. Genet. A 140(8), 914-922 (2006
28. Olson S, Berger AC; Institute of Medicine (US). Challenges and opportunities in using residual newborn screening samples for translational research. National Academies Press, Washington, DC, USA (2010
29. Therrell BL Jr, Hannon WH, Bailey DB Jr et al. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet. Med. 13(7), 621-624 (2011
30. Beskow LM, Friedman JY, Hardy NC, Lin L, Weinfurt KP. Developing a simplified consent form for biobanking. Plos One 5(10), e13302 (2010
31. Winickoff DE, Winickoff RN. The charitable trust as a model for genomic biobanks. N. Engl. J. Med. 349(12), 1180-1184 (2003
32. Rothwell EW, Anderson RA, Burbank MJ et al. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots. Am. J. Public Health 101(11), 2111-2116 (2011
33. Carmichael BM. A spot of trouble. Nature 475, 156-159 (2011
34. Clayton E. Currents in contemporary ethics. State run newborn screening in the genomic era, or how to avoid drowning when drinking from a fire hose J. Law Med. Ethics 38(3), 697-700 (2010
35. Chrysler D, Mcgee H, Bach J, Goldman E, Jacobson PD. The Michigan BioTrust for Health: Using dried bloodspots for research to benefit the community while respecting the individual. J. Law Med. Ethics 39 (SUPPL1), 98-101 (2011
36. Winickoff DE, Winickoff RN. The charitable trust as a model for genomic biobanks. N. Engl. J. Med. 349(12), 1180-1184 (2003
37. Therrell B, Hannon H, Bailey D, Fleischman A, Goldman E. Considerations and recommendations for a national policy regarding the retention and use of dried blood spot specimens after newborn screening. Genet. Med. 13(7), 621-624 (2009
38. McCabe LL, Mccabe ER. Down syndrome: Issues to consider in a national registry, research database and biobank. Mol. Genet. Metab. 104(1-2), 10-12 (2011
39. Moore v. Regents of the Univ. of Cal., 793 P.2d 479 (Cal. 1990), cert. denied, 499 U.S. 936 (1991
40. Greenberg v. Miami Children's Hosp. Research Inst., 264 F. Supp. 2d 1064 (S.D. Fla. 2003
41. Washington University v. Catalona, 490 F.3d 667 (8th Cir. 2007
42. Spliethoff HM, Tao L, Shaver SM et al. Use of newborn screening program blood spots for exposure assessment: Declining levels of perluorinated compounds in New York State infants. Environ. Sci. Technol. 42(14), 5361-5367 (2008
43. McGuire AL, Hamilton JA, Lunstroth R, Mccullough LB, Goldman A. DNA data sharing: Research participants' perspectives. Genet. Med. 10, 46-53 (2008
44. Melas PA, Sjöholm LK, Forsner T et al. Examining the public refusal to consent to DNA biobanking: Empirical data from a Swedish population-based study. J. Med. Ethics 36, 93-98 (2010
45. Roser MA. State sued over babies' blood: Parents say storing samples without consent is illegal. American-Statesman, 18 March (2009
46. Tarini BA, Goldenberg A, Singer D, Clark SJ, Butchart A, Davis MM. Not without my permission: Parents' willingness to permit use of newborn screening samples for research. Public Health Genomics 13(3), 125-130 (2010
47. Botkin JR, Rothwell E, Anderson R et al. Public attitudes regarding the use of residual newborn screening specimens for research. Pediatrics 129, 231-238 (2012
48. Goldenberg AJ, Hull SC, Botkin JR, Wilfond BS. Pediatric biobanks: Approaching informed consent for continuing research after children grow up. J. Pediatr. 155, 578-583 (2009
49. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin. Transl. Sci. 3(1), 42-48 (2010